4.8 Article

High-Contrast Fluorescence Diagnosis of Cancer Cells/Tissues Based on β-Lapachone-Triggered ROS Amplification Specific in Cancer Cells

Journal

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
Volume 60, Issue 23, Pages 12992-12998

Publisher

WILEY-V C H VERLAG GMBH
DOI: 10.1002/anie.202102377

Keywords

cancer; fluorescent probes; imaging agents; near infrared; reactive oxygen species

Funding

  1. National Natural Science Foundation of China [21877077, 22007061, 21778036, 21904082]
  2. Youth Talent Support Program of Shanxi Province
  3. Program for the Top Young Academic Leaders of Higher Learning Institutions of Shanxi
  4. Scientific Instrument Center of Shanxi University

Ask authors/readers for more resources

A new strategy for high-contrast fluorescence diagnosis of cancer cells/tissues based on beta-Lapachone triggered ROS amplification specific in cancer cells/tissues was presented in the study, with average tumor-to-normal ratios far exceeding the clinically acceptable threshold. The strategy also allowed the fluorescence discrimination of tumor tissues from inflammatory ones based on whether a marked fluorescence enhancement could be induced when treated with specific combinations.
Discrimination of cancer cells/tissues from normal ones is of critical importance for early diagnosis and treatment of cancers. Herein, we present a new strategy for high-contrast fluorescence diagnosis of cancer cells/tissues based on beta-Lapachone (beta-Lap, an anticancer agent) triggered ROS (reactive oxygen species) amplification specific in cancer cells/tissues. With the strategy, a wide range of cancer cells/tissues, including surgical tissue specimens harvested from patients, were distinguished from normal ones by using a combination of beta-Lap and a Si-rhodamine-based NIR fluorescent ROS probe PSiR3 developed in this work with average tumor-to-normal (T/N) ratios up to 15 in cell level and 24 in tissue level, far exceeding the clinically acceptable threshold of 2.0. What's more, the strategy allowed the fluorescence discrimination of tumor tissues from inflammatory ones based on whether a marked fluorescence enhancement could be induced when treated with PSiR3 and beta-Lap/PSiR3 combination, respectively.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available